Humanity, Technology and Health Frontiers will be the focus of the Summit, with the program covering topics such as genomics, robotics, 5G technology, private/public partnerships and artificial intelligence.
The GFCC is a global multi-stakeholder organisation represented in more than 30 nations. It promotes innovation, productivity and mutual learning between countries as a way of supporting the ongoing success of a range of sectors, including health.
Noteworthy leaders in the GFCC network Charles Holliday Jr. (Chairman, GFCC and Chairman of Royal Dutch Shell, plc.), Mehmood Kahn (Chairman, U.S. Council on Competitiveness and CEO, Life Biosciences) and Deborah Wince-Smith (President, GFCC and President and CEO, U.S. Council on Competitiveness) will travel to Australia to attend the Summit.
The Morrison Government has committed $300,000 to support the delivery of the Summit.
The Summit will allow Australia to create new partnership opportunities and work with other global leaders to develop innovative health solutions to current and future problems.
Health and innovation are key priorities for the Government, including the recent commitment of $5 billion through the Medical Research Future Fund (MRFF) to support breakthrough medical research into new frontiers of science.
Areas of focus include the transformative platforms of stem cell research and genomics, being able to diagnose, treat, and help people recover with genuine precision medicine.
The Summit agenda will address Australia’s future competitiveness with discussions on navigating the Australian context and opportunities for collaboration between countries.